electroCore, Inc. (ECOR)
USD 5.64
(-4.0%)
USD 5.64
(-4.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 16.03 Million USD | 86.57% |
| 2022 | 8.59 Million USD | 57.62% |
| 2021 | 5.45 Million USD | 55.94% |
| 2020 | 3.49 Million USD | 46.27% |
| 2019 | 2.39 Million USD | 140.7% |
| 2018 | 992.95 Thousand USD | 22.37% |
| 2017 | 811.45 Thousand USD | 219.3% |
| 2016 | 254.13 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.44 Million USD | 4.85% |
| 2024 Q2 | 6.13 Million USD | 12.79% |
| 2023 Q1 | 2.78 Million USD | 8.59% |
| 2023 Q4 | 5.19 Million USD | 15.15% |
| 2023 FY | 16.03 Million USD | 86.57% |
| 2023 Q3 | 4.5 Million USD | 26.95% |
| 2023 Q2 | 3.55 Million USD | 27.73% |
| 2022 Q1 | 1.89 Million USD | 27.38% |
| 2022 FY | 8.59 Million USD | 57.62% |
| 2022 Q4 | 2.56 Million USD | 29.55% |
| 2022 Q3 | 1.97 Million USD | -8.39% |
| 2022 Q2 | 2.15 Million USD | 13.59% |
| 2021 Q3 | 1.48 Million USD | 17.14% |
| 2021 Q4 | 1.49 Million USD | 0.25% |
| 2021 FY | 5.45 Million USD | 55.94% |
| 2021 Q1 | 1.2 Million USD | 29.7% |
| 2021 Q2 | 1.26 Million USD | 5.45% |
| 2020 Q4 | 928.2 Thousand USD | -14.12% |
| 2020 Q1 | 733.8 Thousand USD | 8.71% |
| 2020 FY | 3.49 Million USD | 46.27% |
| 2020 Q2 | 752.95 Thousand USD | 2.61% |
| 2020 Q3 | 1.08 Million USD | 43.55% |
| 2019 Q2 | 622.7 Thousand USD | 52.03% |
| 2019 FY | 2.39 Million USD | 140.7% |
| 2019 Q1 | 409.6 Thousand USD | 11.44% |
| 2019 Q3 | 682.99 Thousand USD | 9.68% |
| 2019 Q4 | 675 Thousand USD | -1.17% |
| 2018 Q3 | 150.97 Thousand USD | -61.58% |
| 2018 FY | 992.95 Thousand USD | 22.37% |
| 2018 Q4 | 367.56 Thousand USD | 143.47% |
| 2018 Q1 | 81.18 Thousand USD | -65.41% |
| 2018 Q2 | 393 Thousand USD | 384.07% |
| 2017 Q1 | 116.93 Thousand USD | 0.0% |
| 2017 Q2 | 176.55 Thousand USD | 50.99% |
| 2017 Q3 | 283.23 Thousand USD | 60.43% |
| 2017 Q4 | 234.73 Thousand USD | -17.13% |
| 2017 FY | 811.45 Thousand USD | 219.3% |
| 2016 FY | 254.13 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -32.93% |
| BrainsWay Ltd. | 31.78 Million USD | 49.567% |
| Cerus Corporation | 156.36 Million USD | 89.748% |
| Envoy Medical, Inc. | 316 Thousand USD | -4972.785% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -2389.13% |
| IceCure Medical Ltd | 3.22 Million USD | -396.439% |
| Inogen, Inc. | 315.66 Million USD | 94.922% |
| OrthoPediatrics Corp. | 148.73 Million USD | 89.222% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -560.214% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -4291.793% |
| MaxCyte, Inc. | 41.28 Million USD | 61.175% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -721.024% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -14374.302% |
| Orthofix Medical Inc. | 746.64 Million USD | 97.853% |
| PAVmed Inc | 2.45 Million USD | -553.752% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 28.816% |
| RxSight, Inc. | 89.07 Million USD | 82.004% |
| Sight Sciences, Inc. | 81.05 Million USD | 80.224% |
| SI-BONE, Inc. | 138.88 Million USD | 88.458% |
| TELA Bio, Inc. | 58.45 Million USD | 72.576% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 91.433% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -16.151% |
| Acutus Medical, Inc. | 7.16 Million USD | -123.758% |
| Talis Biomedical Corporation | 412 Thousand USD | -3790.777% |
| Spectral AI, Inc. | 18.05 Million USD | 11.221% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -61.837% |
| CVRx, Inc. | 39.29 Million USD | 59.206% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -1554.785% |
| Bioventus Inc. | 512.34 Million USD | 96.871% |
| Venus Concept Inc. | 76.35 Million USD | 79.006% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 13.403% |
| LivaNova PLC | 1.15 Billion USD | 98.61% |
| 908 Devices Inc. | 50.22 Million USD | 68.086% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 96.676% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -20706.293% |
| NeuroPace, Inc. | 65.42 Million USD | 75.497% |
| LENSAR, Inc. | 42.16 Million USD | 61.982% |
| Apyx Medical Corporation | 52.34 Million USD | 69.379% |
| Cutera, Inc. | 212.36 Million USD | 92.452% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 51.946% |
| BioSig Technologies, Inc. | 18 Thousand USD | -88955.556% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 90.382% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 33.083% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 98.96% |
| Axonics, Inc. | 366.37 Million USD | 95.625% |
| Outset Medical, Inc. | 130.37 Million USD | 87.705% |
| IRIDEX Corporation | 51.86 Million USD | 69.095% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 88.23% |
| IRadimed Corporation | 65.56 Million USD | 75.55% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -1263.095% |
| INVO Bioscience, Inc. | 3.02 Million USD | -430.694% |
| Telesis Bio, Inc. | 27.5 Million USD | 41.728% |
| Viemed Healthcare, Inc. | 183 Million USD | 91.241% |
| Varex Imaging Corporation | 811 Million USD | 98.023% |
| Quipt Home Medical Corp. | 221.74 Million USD | 92.771% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 76.658% |
| Dynatronics Corporation | 32.53 Million USD | 50.728% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -84.72% |
| Semler Scientific, Inc. | 68.18 Million USD | 76.49% |
| InMode Ltd. | 492.04 Million USD | 96.742% |
| Bruker Corporation | 2.96 Billion USD | 99.459% |
| Cytosorbents Corporation | 36.34 Million USD | 55.9% |
| DexCom, Inc. | 3.62 Billion USD | 99.557% |
| Align Technology, Inc. | 3.86 Billion USD | 99.585% |
| Viveve Medical, Inc. | 6.42 Million USD | -149.455% |
| ZimVie Inc. | 457.43 Million USD | 96.496% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 91.695% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -14374.302% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 97.856% |
| Profound Medical Corp. | 7.33 Million USD | -118.66% |
| Insulet Corporation | 1.69 Billion USD | 99.055% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 87.286% |
| iCAD, Inc. | 17.31 Million USD | 7.437% |
| Nuwellis, Inc. | 8.86 Million USD | -80.844% |
| Biotricity, Inc. | 12.06 Million USD | -32.882% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 96.746% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -158.34% |
| PAVmed Inc. | 2.45 Million USD | -553.752% |
| BIOLASE, Inc. | 49.16 Million USD | 67.395% |
| Beyond Air, Inc. | 1.15 Million USD | -1283.089% |
| FONAR Corporation | 102.88 Million USD | 84.419% |
| AxoGen, Inc. | 159.01 Million USD | 89.919% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 94.159% |
| Inari Medical, Inc. | 493.63 Million USD | 96.753% |
| UFP Technologies, Inc. | 400.07 Million USD | 95.993% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -86082.796% |
| Tenon Medical, Inc. | 2.92 Million USD | -447.473% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -135.319% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.499% |
| Sintx Technologies, Inc. | 2.62 Million USD | -510.202% |
| NanoVibronix, Inc. | 2.28 Million USD | -602.146% |
| Quanterix Corporation | 122.36 Million USD | 86.9% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 34.317% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 92.006% |
| TransMedics Group, Inc. | 241.62 Million USD | 93.366% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -15.707% |
| NeuroMetrix, Inc. | 5.9 Million USD | -171.629% |
| Hyperfine, Inc. | 11.03 Million USD | -45.305% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 90.294% |
| Biomerica, Inc. | 5.41 Million USD | -196.03% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 68.296% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 90.95% |